Lineage Cell Therapeutics, Inc.
LCTX- Exchange
- NYSE
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0000876343
No open-market purchases or sales by Lineage Cell Therapeutics, Inc. insiders were filed in the last 90 days; 131 institutions reported holding it in 13F filings for Q2 2026, worth $152.7M in total; no superinvestor holds it.
Q1 2022 vs. Q4 2021
How the institutions holding Lineage Cell Therapeutics, Inc. changed between Q4 2021 and Q1 2022.
All holders in Q1 2022All holders in Q4 2021
| Measure | Q4 2021 | Of which not filed for Q1 2022 | Q1 2022 | Change |
|---|---|---|---|---|
| Holders | 124 | 1 | 109 | −14 |
| Shares | 74.4M | 2.00K | 72.9M | −1.53M (−2.1%) |
| Value | $182.0M | $5.00K | $112.3M | −$69.6M (−38.3%) |
1 institution that held it in Q4 2021 haven't filed for Q1 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (11)
Institutions that held Lineage Cell Therapeutics, Inc. at the end of Q1 2022 but not at the end of Q4 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Aristides Capital LLC | 100,000 | $154.0K | 0.10% |
| Gsa Capital Partners LLP | 72,506 | $112.0K | 0.02% |
| Barclays PLC | 20,360 | $31.0K | 0.00% |
| Mirabella Financial Services LLP | 18,800 | $29.0K | 0.00% |
| Wealth Architects, LLC | 16,100 | $25.0K | 0.00% |
| Amalgamated Financial Corp. | 15,165 | $23.0K | 0.00% |
| Connor, Clark & Lunn Investment Management Ltd. | 12,000 | $18.0K | 0.00% |
| USAdvisors Wealth Management, LLC | 10,869 | $17.0K | 0.01% |
| Integrated Wealth Concepts LLC | 10,000 | $15.0K | 0.00% |
| Hantz Financial Services, Inc. | 29 | $0 | 0.00% |
| IFP Advisors, Inc | 8 | – | – |
Sold out (25)
Institutions that held Lineage Cell Therapeutics, Inc. at the end of Q4 2021 and filed for Q1 2022 without it.
Not filed for Q1 2022 yet (1)
Institutions that held Lineage Cell Therapeutics, Inc. at the end of Q4 2021 and haven't filed a 13F for Q1 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q4 2021 | Value, Q4 2021 |
|---|---|---|
| Reilly Financial Advisors, LLC | 2,000 | $5.00K |